Medicare AdvantageAdministrativeMedium impact
MA07.055e, Allergy Immunotherapy
Independence Blue Cross·Allergy & Immunology·Medical Policy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA07.055e for Allergy Immunotherapy has been reissued with an effective date of April 1, 2026. This is a policy reissue rather than a new policy change, but billing teams should review the updated policy document for any changes to coverage criteria or billing requirements for allergy immunotherapy services.
Action Required
Before April 1, 2026: Billing team must review the complete updated MA07.055e Allergy Immunotherapy policy at the provided URL to identify any changes to coverage criteria, prior authorization requirements, or billing guidelines. Update billing procedures and staff training as needed based on policy changes identified in the full document.